Investor Relations

Press Releases

Advanced Search
  • Mar 28, 2017
    No Securities Available for Resale Prior to Effectiveness and Nasdaq-related Approvals

    NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that the Company has filed a registration statement on...

  • Mar 28, 2017

    NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief...

  • Mar 21, 2017

    NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced that it has appointed Dennis M. McGrath as its new...

  • Mar 9, 2017
    Aggregate Private Placement Proceeds Exceed $2.5 Million

    NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq:PAVM, PAVMW), a highly differentiated, multi-product medical device company, today announced the closing of approximately $1.0 million in additional...

  • Feb 23, 2017
    Exchange to Provide Incentives for Long-Term Ownership by Existing and New Investors

    NEW YORK--(BUSINESS WIRE)-- PAVmed Inc. (Nasdaq: PAVM, PAVMW) announced today that the Company intends to effectuate a registered exchange offer (the “Exchange”) whereby PAVmed’s Common...